Driving Consistency and Quality Innovation in project management systems is driving a future free of boundaries. Envision a platform that supports COVID-era virtual team collaboration, designed by operations people for operations people. A streamlined, holistic process that offers proactive insights into project health. An approach that makes managing portfolios and …
A Successful Remote Monitoring Strategy for Clinical Studies
Flexible, Efficient Oversight with Data Integrity and Real-Time Communication The COVID-19 pandemic forced study teams to adapt, improvise and overcome as they faced the need to monitor clinical trials, sites and patients from remote locations. Moving forward, we see remote monitoring as part of a successful strategy for managing clinical …
Risk Library: A Proactive Approach to Risk Management for Clinical Studies
Categorizing and centralizing cross-study, cross-functional risk data As part of our Xcellerate® technology suite, we developed a risk library based on cross-functional input identifying the most common risks to our clinical studies, regardless of clinical phase. These common study risks became the foundation of the risk library available to users …
Five Benefits of Risk-Based Quality Management (RBQM) for Clinical Trial Data
Risk-based quality management methodologies address risk control and management during execution of a clinical trial. RBQM adoption has generated valuable benefits for project management and clinical operations, changing the way trial monitoring is done. However, data management activities are ideally suited for an RBQM approach as well. Today, we explore …
Six Automated Clinical Alerts You Need to Increase Efficiency in your Clinical Trials
What is an automated clinical alert? Automated clinical alerts continuously monitor study data and send alerts and notifications to clinical trial project team members based on specific study, country, site or subject performance criteria to help boost clinical study monitoring and improve quality management.
2021: Three Technological Innovations Disrupting the Clinical Trial Landscape
Leveraging science and technology for global impact COVID-19 has spurred disruptive innovation in healthcare and drug development, and we can apply these advances to 2021 and beyond. Our industry’s response to the pandemic has demonstrated our ability to integrate massive amounts of data globally and use technology to apply this …
Clinical oversight during the COVID-19 pandemic: 5 reporting lessons learned
Clinical trial sponsors need the ability to monitor the health of their study or portfolio of studies on an ongoing basis. In times of crises, this becomes a challenging task, as the rapidly evolving situation might render standard reporting tools inadequate and outdated. The Xcellerate® technology suite has been developed …